# US 2008/0188655 A1 · Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188655 A1
- Document ID: US20080188655A1
- Status: Published application
- Kind: A1
- Application number: 12/059,515
- Filed: 2008-03-31
- Published: 2008-08-07
- Earliest claimed: 2002-01-31
- Assignees: Micro Science Tech Co., Ltd.
- Inventors: Woong-Sig Moon; Jae-Chul Kim; Kyoo-Hyun Chung; Ki-Oh Kong; Jung-Hwa Hwang
- Web page: https://patentgrep.com/patent/US20080188655A1

## CPC

- C07D 215/56: with oxygen atoms in position 4
- A01N 43/60: 1,4-Diazines; Hydrogenated 1,4-diazines
- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- C08F 246/00: Copolymers in which the nature of only the monomers in minority is defined
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

The present invention relates to a monomer with anti-microbial characteristics, a polymeric compound with anti-microbial characteristics using the same, and manufacturing methods thereof, and more particularly, to an antimicrobial monomer comprising a saturated or unsaturated hydrocarbon having a polymerizable functional group within its structure. Also, the present invention provides a polymeric compound using the above antimicrobial monomer, a manufacturing method thereof, and a polymeric resin composition. The compounds according to the present invention have durable antimicrobial activity and high heat resistance, they do not give rise to toxicity when added to conventional resins by not eluting the antimicrobial compounds, and they do not have an effect on the properties of molded products.

## Claims

### Claim 1

An antimicrobial monomer compound represented by the following formula 1:
wherein,
R is 10,11-epoxy-2,6-dihydroxy-4,8-dioxaundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2-hydroxy-3-(4-nonylphenoxy)propyl, 2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl, 3-dodecafluoro-2-hydroxy-4-oxaundecyl, 2-hydroxy-3-(methoxy)phenoxypropyl, 2-hydroxy-3-(toluene-4-sulfonyloxy)-propyl, 4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 1-oxo-2-propenyl, 2-methyl-1-oxo-2-propenyl, or 4-vinylbenzyl;
R1 and R2 are each independently or simultaneously hydrogen, a halogen atom, an amine, or a C1˜C20 alkyl group;
R3 and R4 are each independently or simultaneously hydrogen, a hydroxy group, a C1˜C20 alkoxide, a halogen atom, or a C1˜C20 alkyl group;
R5 is hydrogen, a C1˜C20 alkyl, a cyclopropyl, or an aromatic C1˜C20 hydrocarbon;
R6 is hydrogen, sodium, potassium, or a C1˜C150 alkyl group that comprises or does not comprise a polymerizable functional group;
R8, R9, and R10 are each independently or simultaneously carbon or nitrogen; and
R11 is hydrogen, an amine (1°, 2°, 3°), a halogen atom, or a C1˜C20 alkyl group.

### Claim 2 (depends on 1)

The antimicrobial monomer compound of claim 1, characterized in that said antimicrobial monomer compound is selected from the group consisting of 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(10,11-epoxy-2,6-dihydroxy-4,8-dioxaundec yl)-3-methyl-1-piperazinyl]-5-methyl-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-[4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl)-3-methyl-1-piperazinyl]-4-oxo-3-quinoline carboxylic acid, 8-ethyl-5,8-dihydro-2-{4-[2-hydroxy-3-(4-nonylphenoxy)propyl]-1-piperazinyl}-5-oxo pyrido[2,3-d]pyrimidine-6-carboxylic acid, cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl)-3,5-dimethyl-1-piperazinyl]-4-oxo-3-quinoline carboxylic acid, 1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-[4-(2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl)-3-methyl-1-piperazinyl]-4-oxo-3-quinoline carboxylic acid, 1-cyclopropyl-6-fluoro-7-[4-(3-dodecafluoro-2-hydroxy-4-oxaundecyl)-3-methyl-1-pi perazinyl]-1,4-dihydro-5-methyl-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-{4-[2-hydroxy-3-(methoxy)phenoxypropyl}-3-met hyl-1-piperazinyl}-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-{4-[2-hydroxy-3-(toluene-4-sulfonyloxy)-propyl]-1-pip erazinyl}-4-oxo-3-quinoline carboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-hepteny l)-1-piperazinyl]-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-[4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl)-1-pi perazinyl]-4-oxo-3-quinoline carboxylic acid, 8-ethyl-5,8-dihydro-2-[4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl)-1-piperazinyl]-5-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-[4-(1-oxo-2-propenyl)-1-piperazinyl]-4-oxo-3-quinolin e carboxylic acid, and 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(2-methyl-1-oxo-2-propenyl)-1-piperazinyl]-4-oxo-3-quinoline carboxylic acid.

### Claim 3 (depends on 1)

A method of manufacturing the antimicrobial monomer compound of formula 1 of claim 1, comprising the step of reacting a compound of the following formula 2:
wherein R1˜R6 and R8˜R11 are as defined in formula 1 described in claim 1;
with a compound of the following formula 3:
R-Z [Formula 3]
wherein R is as defined in formula 1 described in claim 1, and Z is a halogen atom or a leaving group comprising a tosyl or a mesyl;
at −40 to 130° C. in the presence of a solvent with or without a base.

### Claim 4 (depends on 1)

A method of manufacturing the antimicrobial monomer compound of formula 1 of claim 1, comprising the epoxide ring-opening reaction of a compound of the following formula 2:
wherein R1˜R6 and R8˜R11 are as defined in formula 1 described in claim 1;
with a compound of the following formula 3a:
wherein R7 is 10,11-epoxy-2,6-dihydroxy-4,8-dioxaundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2-hydroxy-3-(4-nonylphenoxy)propyl, 2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl, 3-dodecafluoro-2-hydroxy-4-oxaundecyl, 2-hydroxy-3-(methoxy)phenoxypropyl, 2-hydroxy-3-(toluene-4-sulfonyloxy)-propyl, 4-(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 1-oxo-2-propenyl, 2-methyl-1-oxo-2-propenyl, or 4-vinylbenzyl;
at −40 to 130° C. in the presence of a solvent with or without a base.
